These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9644439)

  • 21. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for ovarian cancer].
    Bjørge T; Dørum A; Tropé CG
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the management of epithelial ovarian cancer.
    Memarzadeh S; Berek JS
    J Reprod Med; 2001 Jul; 46(7):621-9; discussion 629-30. PubMed ID: 11499181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ovarian cancer screening: recommendations for clinical pratice].
    Amram-Benamran ML; Cochet S; Petignat P; Sappino AP
    Rev Med Suisse; 2010 May; 6(250):1062, 1064, 1066-8. PubMed ID: 20564865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for ovarian cancer: is it worth the risk?
    Bell R
    Nurs Times; 1999 Jan 20-26; 95(3):52-3. PubMed ID: 10076394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer. The most lethal gynecologic malignancy.
    Brucks JA
    Nurs Clin North Am; 1992 Dec; 27(4):835-45. PubMed ID: 1448359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for ovarian cancer.
    Goswamy RK; Campbell S; Whitehead MI
    Clin Obstet Gynaecol; 1983 Dec; 10(3):621-43. PubMed ID: 6653033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of cancers of the ovary].
    Juncker L; Blondon J; de Gayffier A
    Rev Prat; 1997 Jun; 47(11):1194-8. PubMed ID: 9238814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of malignant ovarian neoplasms: a review of the literature. I. Detection of the patient at risk; clinical, radiological and cytological detection.
    Smith LH; Oi RH
    Obstet Gynecol Surv; 1984 Jun; 39(6):313-28. PubMed ID: 6374536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of ovarian cancer: a review.
    Yoder LH
    Oncol Nurs Forum; 1990; 17(3):411-5. PubMed ID: 2188227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of ovarian cancer.
    Teneriello MG; Park RC
    CA Cancer J Clin; 1995; 45(2):71-87. PubMed ID: 7889392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.